Alzheimer’s Disease (Mild to Moderate)
![](https://www.wakeclinical.com/wp-content/uploads/2023/07/AthiraAlzheimersCover.jpg)
HAVE YOU OR SOMEONE YOU KNOW BEEN DIAGNOSED WITH ALZHEIMER’S DISEASE?
We are evaluating if a new investigational drug is safe and effective in improving symptoms of mild to moderate Alzheimer’s disease.
Participants must:
- Ages 55-85
- Diagnosed with mild-to-moderate Alzheimer’s disease
- Have a dedicated caregiver
Qualified participants will receive:
- Study-related medication at no cost
- Study-related medical exams at no cost
- Compensation for time
![](https://www.wakeclinical.com/wp-content/uploads/2023/02/MicrosoftTeams-image-10.jpg)
![](https://www.wakeclinical.com/wp-content/uploads/2023/02/white-square.png)
![](https://www.wakeclinical.com/wp-content/uploads/2023/09/5.jpg)
Why Participate?
Contribute to the advancement of medical knowledge and treatments, while receiving expert medical care under close supervision.
![](https://www.wakeclinical.com/wp-content/uploads/2023/09/2.jpg)
Experience
The M3 Wake Research Network has powered innovation with over 9,100 Successful Clinical Trials in patients from 6 months to 85 years.
![](https://www.wakeclinical.com/wp-content/uploads/2023/09/4.jpg)
Safety
Patient safety is paramount with strict protocols and ethical guidelines, minimizing risks and ensuring thorough monitoring throughout the trial.
![](https://www.wakeclinical.com/wp-content/uploads/2022/12/news-bg.jpg)
Multi-Specialty Research Associates
Main Office
+1-386-438-8977
Fax
+1-386-438-8972
Email
info@msrainc.com
Our Location
4601 W US 90
Lake City, FL 32055